The startup has created a wearable head sensor and software that lets therapists monitor patient symptoms, prescribe and record activities that patients complete, and ultimately learn more about how well therapies are working.
Patients can do at-home rehabilitation activities more accurately because to technology.
Ten new jobs will be created as a result of the money, which will also enable the team to carry out product development and enter the US and UK markets.
Currently, over 1,000 patients and clinics in Ireland are using the company’s software. It intends to launch into the US market early in 2019 and the UK market in the middle of 2024.
“Worldwide, patients who have been diagnosed with vertigo can face months-long waiting lists or an inability to get access to treatment at all,” stated Mark Barry, CEO of Vertigenius.
“Our mission is to enable early access to high-quality care for vertigo patients, which will improve the lives of millions of people,” stated Barry.
Ascentifi and Enterprise Ireland were among the investors in the fundraising round managed by Atlantic Bridge.
“We are excited to collaborate with Vertigenius as they lead the way in treating vertigo,” stated Atlantic Bridge’s investment director Conor O’Sullivan.
“The company’s innovative approach, based on technology developed by Dr Dara Meldrum at Trinity College Dublin, combined with their experienced team led by Mark Barry, and strong market potential, positions the company for significant success,” said Mr O’Sullivan.